Ryan Specialty Holdings, Inc. (NYSE:RYAN) Receives Consensus Rating of “Hold” from Analysts

Ryan Specialty Holdings, Inc. (NYSE:RYAN) has been given an average recommendation of “Hold” by the thirteen analysts that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and six have assigned a buy rating to the company. The average 1-year target price among brokerages that have updated their coverage on the stock in the last year is $75.27.

Several equities research analysts recently commented on RYAN shares. Royal Bank of Canada cut their price objective on shares of Ryan Specialty from $73.00 to $72.00 and set a “sector perform” rating on the stock in a research report on Friday, February 21st. Wells Fargo & Company boosted their price target on Ryan Specialty from $64.00 to $69.00 and gave the company an “equal weight” rating in a report on Friday, February 21st. Morgan Stanley began coverage on Ryan Specialty in a report on Thursday, December 5th. They set an “overweight” rating and a $90.00 price objective for the company. Keefe, Bruyette & Woods reduced their price target on Ryan Specialty from $77.00 to $76.00 and set an “outperform” rating for the company in a research report on Friday, February 21st. Finally, UBS Group lifted their price objective on shares of Ryan Specialty from $82.00 to $84.00 and gave the company a “buy” rating in a report on Wednesday, February 26th.

Insiders Place Their Bets

In other news, Director Nicholas Dominic Cortezi sold 29,466 shares of the stock in a transaction dated Monday, January 13th. The shares were sold at an average price of $65.06, for a total value of $1,917,057.96. Following the transaction, the director now directly owns 45,409 shares of the company’s stock, valued at $2,954,309.54. This represents a 39.35 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Brendan Martin Mulshine sold 30,000 shares of the company’s stock in a transaction dated Friday, March 14th. The shares were sold at an average price of $69.30, for a total transaction of $2,079,000.00. The disclosure for this sale can be found here. Insiders have sold a total of 241,360 shares of company stock valued at $16,006,428 over the last 90 days. 11.10% of the stock is currently owned by insiders.

Institutional Trading of Ryan Specialty

Several institutional investors have recently added to or reduced their stakes in RYAN. Wellington Management Group LLP acquired a new stake in shares of Ryan Specialty during the fourth quarter worth $29,599,000. Wealth Enhancement Advisory Services LLC increased its position in Ryan Specialty by 3.7% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 11,755 shares of the company’s stock worth $754,000 after acquiring an additional 420 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in Ryan Specialty by 14.1% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 299,156 shares of the company’s stock valued at $19,194,000 after purchasing an additional 36,990 shares during the period. Voloridge Investment Management LLC grew its position in shares of Ryan Specialty by 4.7% during the 4th quarter. Voloridge Investment Management LLC now owns 609,995 shares of the company’s stock worth $39,137,000 after purchasing an additional 27,657 shares in the last quarter. Finally, Sone Capital Management LLC bought a new position in shares of Ryan Specialty during the fourth quarter worth approximately $8,303,000. 84.82% of the stock is currently owned by institutional investors.

Ryan Specialty Stock Up 1.8 %

Shares of Ryan Specialty stock opened at $75.14 on Thursday. The company has a market capitalization of $19.68 billion, a P/E ratio of 108.90, a price-to-earnings-growth ratio of 1.19 and a beta of 0.71. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. The business has a 50-day moving average of $69.22 and a two-hundred day moving average of $68.51. Ryan Specialty has a 1 year low of $48.48 and a 1 year high of $75.97.

Ryan Specialty (NYSE:RYAN) last posted its earnings results on Thursday, February 20th. The company reported $0.45 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.02). The business had revenue of $663.53 million for the quarter, compared to the consensus estimate of $658.80 million. Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. As a group, equities analysts predict that Ryan Specialty will post 2.29 EPS for the current year.

Ryan Specialty Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Tuesday, March 4th were issued a dividend of $0.12 per share. The ex-dividend date of this dividend was Tuesday, March 4th. This represents a $0.48 dividend on an annualized basis and a yield of 0.64%. This is a boost from Ryan Specialty’s previous quarterly dividend of $0.11. Ryan Specialty’s dividend payout ratio (DPR) is presently 69.57%.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.